Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 11, 2026 | Capital Blue Cross | Paraspinal Surface Electromyography to Evaluate and Monitor Back PainPayerPolicy · CAPBLUE-MP-2.097 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Other Therapies of HyperhidrosisPayerPolicy · CAPBLUE-MP-2.005 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Orthopedic Applications of Stem Cell Therapy (Including Allograft and Bone Substitute Products Used with Autologous Bone Marrow)PayerPolicy · CAPBLUE-MP-2.080 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Orthopedic Applications of Platelet Rich PlasmaPayerPolicy · CAPBLUE-MP-4.039 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Orthognathic SurgeryPayerPolicy · CAPBLUE-MP-1.101 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Orphan Drugs and Humanitarian Use DevicesPayerPolicy · CAPBLUE-MP-2.383 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Optical Coherence Tomography (OCT) of the Anterior Eye SegmentPayerPolicy · CAPBLUE-MP-2.085 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Ophthalmologic Techniques That Evaluate the Posterior Eye SegmentPayerPolicy · CAPBLUE-MP-2.056 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)PayerPolicy · CAPBLUE-MP-2.083 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Oncological Applications of Photodynamic Therapy including Barrett's EsophagusPayerPolicy · CAPBLUE-MP-4.019 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Off-Label Use of Medications and other InterventionsPayerPolicy · CAPBLUE-MP-2.103 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Occipital Nerve StimulationPayerPolicy · CAPBLUE-MP-2.372 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Nonpharmacologic Treatment of RosaceaPayerPolicy · CAPBLUE-MP-2.071 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Noninvasive Imaging for the Evaluation and Monitoring of Patients with Chronic Liver DiseasePayerPolicy · CAPBLUE-MP-2.252 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNAPayerPolicy · CAPBLUE-MP-2.261 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Noncontraceptive Use of Intrauterine Devices (IUDs)PayerPolicy · CAPBLUE-MP-7.026 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Non-Emergent Ground Transport ServicesPayerPolicy · CAPBLUE-MP-3.009 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Next-Generation Sequencing For The Assessment of Measurable Residual DiseasePayerPolicy · CAPBLUE-MP-2.379 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Neuromuscular and Functional Neuromuscular Electrical StimulationPayerPolicy · CAPBLUE-MP-6.051 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Neural TherapyPayerPolicy · CAPBLUE-MP-8.012 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Negative Pressure Wound Therapy in the Outpatient SettingPayerPolicy · CAPBLUE-MP-4.004 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Navigated Transcranial Stimulation (nTMS)PayerPolicy · CAPBLUE-MP-2.094 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Multimarker Serum Testing Related to Ovarian CancerPayerPolicy · CAPBLUE-MP-2.270 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Multicancer Early Detection TestingPayerPolicy · CAPBLUE-MP-2.387 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Molecular Testing in the Management of Pulmonary NodulesPayerPolicy · CAPBLUE-MP-2.375 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Molecular Testing for The Management of Pancreatic Cysts and Solid Pancreaticobiliary LesionsPayerPolicy · CAPBLUE-MP-2.266 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Molecular Testing for Germline Variants Associated with Ovarian Cancer (BRIP1, RAD51C, RAD51D, NBN)PayerPolicy · CAPBLUE-MP-2.377 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Molecular Panel Testing of Cancers to Identify Targeted TherapiesPayerPolicy · CAPBLUE-MP-2.259 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Molecular Markers in Fine Needle Aspirates of the ThyroidPayerPolicy · CAPBLUE-MP-2.275 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Minimally Invasive Ablation Procedures for Morton and Other Peripheral NeuromasPayerPolicy · CAPBLUE-MP-2.084 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Microwave Tumor AblationPayerPolicy · CAPBLUE-MP-2.090 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Medical Treatments of Autism Spectrum DisordersPayerPolicy · CAPBLUE-MP-2.304 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Medical NecessityPayerPolicy · CAPBLUE-MP-4.003 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Medical Management of Obstructive Sleep Apnea SyndromePayerPolicy · CAPBLUE-MP-6.064 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Mechanical Insufflation Exsufflation DevicePayerPolicy · CAPBLUE-MP-6.022 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Measurement of Exhaled Nitric Oxide in the Diagnosis and Management of Asthma and Other Respiratory DisordersPayerPolicy · CAPBLUE-MP-4.038 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Manual Wheelchairs and AccessoriesPayerPolicy · CAPBLUE-MP-6.059 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Magnetic Resonance-Guided Focused UltrasoundPayerPolicy · CAPBLUE-MP-5.053 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux DiseasePayerPolicy · CAPBLUE-MP-1.145 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Lysis of Epidural AdhesionsPayerPolicy · CAPBLUE-MP-6.027 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Lung and Lobar Lung TransplantPayerPolicy · CAPBLUE-MP-9.015 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Lower Limb ProsthesesPayerPolicy · CAPBLUE-MP-6.042 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Low Level Laser TherapyPayerPolicy · CAPBLUE-MP-1.097 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Low Intensity Pulsed Ultrasound Fracture Healing DevicePayerPolicy · CAPBLUE-MP-6.021 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Liver Transplant and Combined Liver-Kidney TransplantPayerPolicy · CAPBLUE-MP-9.006 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Light TherapiesPayerPolicy · CAPBLUE-MP-2.046 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Laser Treatment of Port Wine StainsPayerPolicy · CAPBLUE-MP-1.008 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Laser Treatment for Vulvovaginal Atrophy and Vaginal RejuvenationPayerPolicy · CAPBLUE-MP-4.047 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid MyolysisPayerPolicy · CAPBLUE-MP-7.027 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Laboratory and Genetic Testing for Use of 5-Flourouracil in Patients with CancerPayerPolicy · CAPBLUE-MP-2.354 | Metadata changed |
|---|